Understanding Treatment-Resistant Symptoms Globally, as many as 60% of patients suffering from neurological, psychiatric, and behavioural disorders do not respond to standard treatments (1). This

In an exciting new development, a team of esteemed researchers led by Professor Douglas Kell from the University of Liverpool, alongside Professor E. Pretorius and

Maintrac® is a revolutionary approach to cancer support, embodying the new paradigm of personalised medicine. Its primary goal is to monitor primary and secondary malignancies

In the realm of health mysteries, there’s often more to a condition than meets the eye. Kryptopyrroluria (KPU) stands as a prime example – a